scotty3371,
Maybe those thinking longer term would rather not waste money on clean rooms that won’t be needed for very long and are very high maintenance. Maybe product release is a bottleneck that needs to be resolved. Maybe the bigger boat has more to do with advancing Edens to accommodate future demand from an approval EVEN IF Edens is not technically “required” for approval. Maybe the thinking is more “patients first” than “penny traders first”. In other words, maybe what you want, to benefit your way of doing things just isn’t as important as what is best for patient access once an approval is granted. Maybe the goal is to have Edens ready ASAP once approval is given so that access is widely available to patients once “the process” is completed and reimbursement is in place. Hmm. Put the two in a balancing scale and see what happens. Pennies or PATIENTS.. pennies or PATIENTS, pennies or PATIENTS?; ). Best wishes.
Market Data 
Markets 
AI
